Harnessing the Power of Innovation and Collaboration: Key Takeaways ASCO 2024

Read article

Harnessing the Power of Innovation and Collaboration: Key Takeaways ASCO 2024

The 2024 ASCO Annual Meeting presents an unmissable…
Read Article

Embracing AI in Clinical Trials: An Oncology CRO’s Insight

In our previous article, we outlined how AI…
Read Article

Transforming Oncology Drug Development with Artificial Intelligence

The release of GPT 3.5 and the improvement…
Read Article

FDA’s New Guidance on Diversity in Clinical Trials: New Challenges for Patient Recruitment

The U.S. Food and Drug Administration (FDA) recently…
Read Article

The Poster Child of International Clinical Trial Success: Legend Biotech’s Carvykti/Cilta-cel Immunotherapy Achieves FDA Approval

With many in biotech and pharma in China…
Read Article

Chinese Clinical Trial Data – Still Relevant to the FDA

For Chinese companies bringing oncology drugs to the…
Read Article

A Decade Later, Patient Receiving CAR T-Cell Therapy “Cured of Cancer”

February 2022 has been an important month in…
Read Article

Rescuing an Oncology Study in the U.S.

When startup biotech or pharma companies are conducting…
Read Article

CAR T-Cell Therapies – Now Targeting Solid Tumors

Most in oncology drug development are aware of…
Read Article